Heart disease is the leading cause of death in the EU. To tackle this, EU researchers are developing a new diagnosis method that could revolutionise how we prevent heart problems.
Researchers working within the EU-funded NanoMate project are using gold nanoparticles to identify and measure inflammation in diseased blood vessel walls, which is a predictor of heart disease. This method will allow clinicians to identify a person at risk of heart attack at an early stage, so that preventative actions can be taken.
Further details: Tiny gold nanoparticles could change how we monitor and treat heart disease